Squarepoint
DPLO

Squarepoint’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

Squarepoint’s Portfolio DPLO Stock Details DPLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-38,071
Closed -$152K – 2831
2019
Q4 		$152K Sell
38,071
-159,089
-81% -$747K ﹤0.01% 2277
2019
Q3 		$966K Buy
197,160
+97,060
+97% +$543K 0.01% 1266
2019
Q2 		$610K Buy
100,100
+41,767
+72% +$222K 0.01% 1546
2019
Q1 		$339K Buy
+58,333
New +$602K ﹤0.01% 1706
2018
Q2 		– Sell
-77,068
Closed -$1.55M – 2200
2018
Q1 		$1.55M Buy
77,068
+43,867
+132% +$1.02M 0.02% 652
2017
Q4 		$666K Buy
+33,201
New +$653K 0.01% 1022
2017
Q1 		– Sell
-19,454
Closed -$245K – 2090
2016
Q4 		$245K Buy
19,454
+6,320
+48% +$118K 0.01% 1282
2016
Q3 		$368K Buy
+13,134
New +$441K 0.02% 666

Other funds holding DPLO

GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Squarepoint's DPLO Position: Q1 2020 in Review

Squarepoint sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q1 2020, closing a stake of 38,071 shares — an estimated $152K sold.

Squarepoint first reported a position in DPLO in Q3 2016 and held it in 8 quarters. The position peaked at $1.55M in Q1 2018. 1 fund tracked by Wall St. Rank holds DPLO as of Q1 2020.

  • Squarepoint reported no remaining DIPLOMAT PHARMACY, INC. position as of Q1 2020 after selling out during the quarter.
  • Squarepoint sold 38,071 DIPLOMAT PHARMACY, INC. shares in Q1 2020, an estimated $152K.
  • Squarepoint first reported a position in DIPLOMAT PHARMACY, INC. in Q3 2016 and held it in 8 quarters.
  • Squarepoint's DIPLOMAT PHARMACY, INC. position peaked at $1.55M in Q1 2018.
  • 1 fund tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q1 2020.

Based on Squarepoint's 13F filing for Q1 2020, filed 15 May 2020.